Bank of New York Mellon’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.7M | Buy |
485,865
+183,201
| +61% | +$15.3M | 0.01% | 1122 |
|
|
2025
Q1 | $21.6M | Buy |
302,664
+234,649
| +345% | +$16.8M | ﹤0.01% | 1464 |
|
|
2024
Q4 | $3.06M | Buy |
68,015
+4,260
| +7% | +$191K | ﹤0.01% | 2541 |
|
|
2024
Q3 | $3.22M | Sell |
63,755
-25,044
| -28% | -$1.26M | ﹤0.01% | 2527 |
|
|
2024
Q2 | $3.62M | Buy |
+88,799
| New | +$3.62M | ﹤0.01% | 2489 |
|
|
2024
Q1 | – | Sell |
-9,936
| Closed | -$400K | – | 4288 |
|
|
2023
Q4 | $400K | Buy |
9,936
+449
| +5% | +$18.1K | ﹤0.01% | 3671 |
|
|
2023
Q3 | $280K | Buy |
+9,487
| New | +$280K | ﹤0.01% | 3823 |
|
|
2022
Q3 | – | Sell |
-2,818
| Closed | -$8K | – | 4594 |
|
|
2022
Q2 | $8K | Hold |
2,818
| – | – | ﹤0.01% | 4559 |
|
|
2022
Q1 | $9K | Hold |
2,818
| – | – | ﹤0.01% | 4641 |
|
|
2021
Q4 | $17K | Hold |
2,818
| – | – | ﹤0.01% | 4593 |
|
|
2021
Q3 | $39K | Hold |
2,818
| – | – | ﹤0.01% | 4461 |
|
|
2021
Q2 | $48K | Sell |
2,818
-7,984
| -74% | -$136K | ﹤0.01% | 4325 |
|
|
2021
Q1 | $205K | Sell |
10,802
-529
| -5% | -$10K | ﹤0.01% | 4047 |
|
|
2020
Q4 | $328K | Buy |
11,331
+3,231
| +40% | +$93.5K | ﹤0.01% | 3790 |
|
|
2020
Q3 | $305K | Buy |
8,100
+2,921
| +56% | +$110K | ﹤0.01% | 3713 |
|
|
2020
Q2 | $173K | Buy |
+5,179
| New | +$173K | ﹤0.01% | 3829 |
|
|
2019
Q4 | – | Sell |
-1,069
| Closed | -$24K | – | 4221 |
|
|
2019
Q3 | $24K | Sell |
1,069
-107
| -9% | -$2.4K | ﹤0.01% | 4164 |
|
|
2019
Q2 | $49K | Buy |
+1,176
| New | +$49K | ﹤0.01% | 4114 |
|